YMAB•benzinga•
Reported Monday, Y-mAbs Highlights Ongoing Phase 1 Trial Of GD2-SADA PRIT With 177Lu-DOTA At ANR 2025 In Washington, D.C.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 27, 2025 by benzinga